Table of Contents
- Serzone and Nefazodone: News, Research, and Litigation
- January 2002: FDA Requires New Black Box Warning on Serzone
- March 22, 2004: FDA Asks Antidepressant Manufacturers To Advise Observation of Patients
- March 15, 2004: Public Citizen Group Sues FDA Over Failure to Ban Serzone
- May 19, 2004: Bristol Myers Squibb Announces U.S. Sales of Serzone to End in June
- 2005: Thousands of Patients Sue Bristol Myers Squibb Over Serzone
- Is the Generic Version of Serzone Dangerous?
- What To Do if You Become Sick After Taking Nefazodone
- Conclusion
Ready to Publish
Ready to Publish
Author
OG Image (1200x630)
Excerpt
This blog post delves into the history, risks, and ongoing litigation surrounding Serzone and its generic counterpart, nefazodone, highlighting significant health concerns such as liver damage. If you or a loved one has experienced adverse effects from these medications, seeking legal advice from an experienced attorney near you could be crucial in exploring your options for justice.
Meta Description
This blog post explores the history, risks, and legal implications of Serzone and its generic version, nefazodone, focusing on health concerns such as liver damage and mental health risks. If you or a loved one has been affected, consult a qualified attorney near you to discuss your legal options and seek justice.
Slug
personal-injury/common-personal-injury-cases-legal-implications/medical-drug-legal-issues/serzone-nefazodone-news-research-litigation-liver-damage
Alt Image Text
Heroic attorney standing on a cracked glowing pill, shielding individuals from risks like liver damage and mental health concerns, with a generic corporate building in the background symbolizing pharmaceutical scrutiny.
Related Posts
Global Tags
Parent item
Sub-item
Hide in Main Feed
Hide in Main Feed
Post Id
674
Updated
Jan 28, 2025 08:36 PM
Featured
Featured
Hide CTA
Hide CTA
Hide Cover
Hide Cover
Serzone and Nefazodone: News, Research, and Litigation
Serzone (nefazodone) was introduced by Bristol Myers Squibb in 1994 as an antidepressant for treating major depressive disorder and anxiety. Unlike most antidepressants, Serzone was not a selective serotonin reuptake inhibitor (SSRI), and it was marketed as causing less weight gain. However, the drug was discontinued in 2004 due to safety concerns, particularly liver damage. This guide explores the history, risks, and legal actions related to Serzone and its generic version, nefazodone.
💡 For every post in this series, scroll down to “Related Posts.”
January 2002: FDA Requires New Black Box Warning on Serzone
In 2002, the FDA mandated a black box warning on Serzone packaging due to increased liver failure risks. Clinical trials indicated that patients on Serzone were three to four times more likely to develop liver disease compared to those on a placebo. Many required liver transplants, and some died.
March 22, 2004: FDA Asks Antidepressant Manufacturers To Advise Observation of Patients
The FDA issued a Public Health Advisory urging antidepressant manufacturers to include warnings about monitoring patients for increased depression or suicidal thoughts. This applied to Serzone, Prozac, Zoloft, Paxil, and others.
March 15, 2004: Public Citizen Group Sues FDA Over Failure to Ban Serzone
Public Citizen sued the FDA for not banning Serzone, arguing that the agency's inaction was illegal and seeking regulatory action against the drug's manufacturer.
May 19, 2004: Bristol Myers Squibb Announces U.S. Sales of Serzone to End in June
Bristol Myers Squibb announced the discontinuation of Serzone in the U.S. due to declining sales, not safety concerns.
2005: Thousands of Patients Sue Bristol Myers Squibb Over Serzone
In 2005, thousands of plaintiffs filed a class action lawsuit against Bristol Myers Squibb, alleging that Serzone caused liver injury and death. The case settled for over $70 million, but some plaintiffs opted out to continue their claims.
Is the Generic Version of Serzone Dangerous?
The generic version, nefazodone, remains available despite evidence of similar risks. A 2020 study highlighted severe health risks, including serotonin syndrome, glaucoma, angioedema, Stevens-Johnson syndrome, seizures, and increased liver injury.
What To Do if You Become Sick After Taking Nefazodone
If you experience adverse effects from nefazodone or any antidepressant, seek medical attention immediately. Consult a product liability attorney to explore legal options, as the statute of limitations for Serzone has passed, but claims for nefazodone may still be viable.
Conclusion
Serzone and nefazodone pose significant health risks, particularly liver damage. Understanding these risks and seeking legal advice can help affected individuals explore their options. If you experience health issues related to these drugs, consult a healthcare professional and a product liability attorney.
ReferU.AI is the only platform that leverages AI to efficiently and accurately assess each user's unique legal needs and objectively recommend attorneys based on their proven success in similar cases according to actual court records. By providing smarter results, users gain easier access to better representation and outcomes. For more information, visit ReferU.AI.
Written by
